{"id":5097,"date":"2021-08-12T18:27:23","date_gmt":"2021-08-12T23:27:23","guid":{"rendered":"https:\/\/sites.une.edu\/research\/?p=5097"},"modified":"2021-08-12T18:27:24","modified_gmt":"2021-08-12T23:27:24","slug":"unes-stephanie-nichols-co-authored-safety-of-ect-in-patients-receiving-an-oral-anticoagulant-published-in-mental-health-clinician-with-colleagues-from-maine-medical-center","status":"publish","type":"post","link":"https:\/\/sites.une.edu\/research\/unes-stephanie-nichols-co-authored-safety-of-ect-in-patients-receiving-an-oral-anticoagulant-published-in-mental-health-clinician-with-colleagues-from-maine-medical-center\/","title":{"rendered":"UNE&#8217;s Stephanie Nichols co-authored \u201cSafety of ECT in patients receiving an oral anticoagulant,\u201d published in Mental Health Clinician, with colleagues from Maine Medical Center."},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">doi:\u00a0<a rel=\"noreferrer noopener\" href=\"https:\/\/dx.doi.org\/10.9740%2Fmhc.2021.07.254\" target=\"_blank\">10.9740\/mhc.2021.07.254<\/a><\/h2>\n\n\n\n<p>ECT is an important treatment for patients with major depression, catatonia, and other psychiatric disorders and<br>conditions. Among patients with depression, ECT is effective at attaining remission in 50% to 60%, compared<br>with 10% to 40% remission rates with pharmacotherapy or psychotherapy.1 A recent review2 reported successful<br>completion of ECT in 3 patients with cerebral aneurysms taking an anticoagulant or antiplatelet medication.<br>Nevertheless, ECT may be associated with an increased risk of complications when used in patients with some<br>medical conditions, including unstable or severe cardiovascular disease, aneurysm or vascular malformation, increased intracranial pressure, recent cerebral infarct, pulmonary conditions, and those at high risk of complications<br>associated with anesthesia.<\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>doi:\u00a010.9740\/mhc.2021.07.254 ECT is an important treatment for patients with major depression, catatonia, and other psychiatric disorders &hellip;<\/p>\n","protected":false},"author":49,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[21],"tags":[],"post_folder":[],"class_list":["post-5097","post","type-post","status-publish","format-standard","hentry","category-publications-and-awards"],"acf":[],"_links":{"self":[{"href":"https:\/\/sites.une.edu\/research\/wp-json\/wp\/v2\/posts\/5097","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sites.une.edu\/research\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sites.une.edu\/research\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sites.une.edu\/research\/wp-json\/wp\/v2\/users\/49"}],"replies":[{"embeddable":true,"href":"https:\/\/sites.une.edu\/research\/wp-json\/wp\/v2\/comments?post=5097"}],"version-history":[{"count":6,"href":"https:\/\/sites.une.edu\/research\/wp-json\/wp\/v2\/posts\/5097\/revisions"}],"predecessor-version":[{"id":5103,"href":"https:\/\/sites.une.edu\/research\/wp-json\/wp\/v2\/posts\/5097\/revisions\/5103"}],"wp:attachment":[{"href":"https:\/\/sites.une.edu\/research\/wp-json\/wp\/v2\/media?parent=5097"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sites.une.edu\/research\/wp-json\/wp\/v2\/categories?post=5097"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sites.une.edu\/research\/wp-json\/wp\/v2\/tags?post=5097"},{"taxonomy":"post_folder","embeddable":true,"href":"https:\/\/sites.une.edu\/research\/wp-json\/wp\/v2\/post_folder?post=5097"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}